Comprehensive Overview of Asthma Causes and Treatment

Introduction 

Asthma is a chronic inflammatory disorder of the airways which can occur to people of any age. As Hammad and Lambrecht (2021) stated, this type of asthma is marked by frequent attacks of wheezing, shortness of breath, coughing, and chest tightness. Although asthma is incurable, it can be efficiently managed with appropriate treatment and precautions. This report aims at giving a general account of asthma, including its cause, pathogenesis, diagnosis, treatment, drugs, asthma action plan, and a current issue relating to the disease.

Etiology

The exact reason why a person gets asthma is not exactly known. However, it is believed that asthma is caused by the combination of genetic and environmental factors. According to Nuzzi et al. (2022), hereditary factors lead to the predisposition of an individual to asthma with some genes being identified as contributing players in the condition. The environmental factors like exposure to allergens (dust mites, pollen, animal dander), respiratory infections, air pollution, and active smoking can cause or worsen asthmatic symptoms (Asthma, 2023).

Pathophysiology

Asthma, being an inflammatory condition, affects the airways (bronchi and bronchioles) of the lungs (Asthma, 2023). When the inflammation occurs, the airways get inflamed, narrowed and hypersensitive which lets the air move in and out of the lungs with great difficulty. These airway obstructions can result in symptoms that include wheezing, coughing, chest tightness, and shortness of breath (Nuzzi et al., 2022). As per Hammad and Lambrecht (2020), the inflammation is initiated by the exposure to the particular stimuli including allergens, respiratory infections or irritants.

Diagnosis

Generally, asthma is diagnosed through the combination of patient history, physical examination, and lung function tests. The medical history includes assembling data about the patient’s symptoms, family history, and triggers or exposures (Xu et al., 2022). During a physical exam, a doctor may hear wheezing or other signs of an obstructed airway. Lung function tests, including spirometry, measure performance of the lungs and can help diagnose asthma and assess its severity.

Treatment

In accordance with National Heart, Lung, and Blood Institute (2020), the main objectives of asthma treatment are to control symptoms, prevent flare-ups, and provide normal lung function. Treatment in most cases employs a blend of medications and lifestyle changes. The crucial thing in asthma management is avoiding triggers such as allergens or environmental irritants.

Medications

There are several categories of medications used to treat asthma:

1. Bronchodilators:

1. Short-acting beta-agonists (SABAs): These drugs work rapidly by dilating and relaxing the airways, according to Nuzzi et la. (2022). Cases include albuterol (Ventolin, Proair) and levalbuterol (Xopenex).
2.  Long-acting beta-agonists (LABAs): These drugs are long-term acting and are administered together with inhaled corticosteroids (Asthma, 2023). Examples of these drugs are salmeterol (Serevent) and formoterol (Foradil).

1. Inhaled corticosteroids: If these medications are given, it significantly reduces the swelling in the airway and is the most effective chronic medication treating asthma (Hammad & Lambrecht, 2021). These antigenic examples include fluticasone (Flovent), budesonide (Pulmicort), and beclomethasone respectively.
2. Leukotriene modifiers: It is by this means that leukotriene antagonists work as these are responsible for the inflammatory processes associated with asthma (Asthma, 2023). For example these include beclomethasone (Qvar) and montelukast (Singulair).
3. Combination inhalers: Such meds that contain the bronchodilator (LABA) and the inhaled steroid as monotherapy (Xu et al., 2022) are used. For instance, we may refer fluticasone/salmeterol (Advair Diskus) and budesonide/formoterol (Symbicort).

Asthma Action Plan

A personalized asthma action plan is a written document generated by a healthcare provider with the patient as the main player. It presents practical pre-emptive and responsive measures for managing the condition on day-to-day basis and recognizing and responding to potentially alarming symptoms or asthma attack. Based on Xu et al. (2022), the usual plan walks one through what to do with medications, how to track his/hremailponizing symptoms, identifying triggers, and seeking medical help in case of an emergency.

Current Event

The FDA, USA, granted the approval to a new inhaler corticosteroid called Trelegy Ellipta in January 2022 to treat adults with asthma for their long-term management in January 2022 (Asthma, 2023). According the the National Heart, Lung, and Blood Institute (2020), Trelegy Ellipta is a combination drug which is made up with three different kinds of medication that includes: fluticasone furoate (inhaled synthetic corticosteroid), umeclidinium (a long-acting muscarinic antagonist), and vilanterol (a long-acting beta- As per the research by Xu et al. (2022), this new drug is developed as a treatment that has shown to be better in controlling symptoms and reduces the risk of asthmatic attacks.

Conclusion

In summary, asthma has become a serious chronic illness which is in need of continued management and therapy. In order to implement an efficient management, being knowledgeable in terms of etiology, pathophysiology, and diagnostic methods is of tremendous significance. Treatment incorporates a group of medicines, amongst them inhaled steroid use, the exit from triggers and put in writing of the asthma action plan. However, there is no known remedy for an asthma; nevertheless, the outstanding action plan could help the sufferer to be disciplined and live an active life and not be restricted in their activities. On the other hand, constant in-depth studies and innovations in medicines are making new generation drugs and treatment options for better management of asthma possible, as, for instance, the newest Trelegy Ellipta proven.

References

Asthma. (2023). In Encyclopædia Britannica. https://www.britannica.com/science/asthma [Encyclopedia]

Hammad, H., & Lambrecht, B. N. (2021). The basic immunology of asthma. Cell, 184(6), 1469-1485. https://www.cell.com/cell/pdf/S0092-8674(21)00166-5.pdf [Journal Article]

National Heart, Lung, and Blood Institute. (2020). Asthma. Retrieved from: https://www.nhlbi.nih.gov/health-topics/asthma [Website]

Nuzzi, G., Di Cicco, M., Trambusti, I., Agosti, M., Peroni, D. G., & Comberiati, P. (2022). Primary prevention of pediatric asthma through nutritional interventions. Nutrients, 14(4), 754. https://doi.org/10.3390/nu14040754 [Journal Article]

Xu, S., Panettieri Jr, R. A., & Jude, J. (2022). Metabolomics in asthma: A platform for discovery. Molecular aspects of medicine, 85, 100990. https://doi.org/10.1016/j.mam.2021.100990 [Journal Article]